Fig. 2
Abdominal computed tomography (CT) findings after four cycles of nivolumab. Abdominal enhanced-contrast CT revealed a marked reduction (by 55%) in liver metastases (arrows)
Fig. 2 | Surgical Case Reports
Abdominal computed tomography (CT) findings after four cycles of nivolumab. Abdominal enhanced-contrast CT revealed a marked reduction (by 55%) in liver metastases (arrows)